Assembling intelligence…
IDIQ FOR CANCER THERAPY DRUGS: LUTATHERA AND PLUVICTO
| Company | Orders | Obligated | Latest order end |
|---|---|---|---|
| ADVANCED ACCELERATOR APPLICATIONS USA INC | 1 | $3.4M | 2025-09-30 |
| NOVARTIS PHARMACEUTICALS CORPORATION | 1 | $3.2M | 2026-09-30 |
| W81K0024F0177 ADVANCED ACCELERATOR APPLICATIONS USA INC · Department of the Army | $3.4M | 2025-09-30 |
| W81K0025FA195 NOVARTIS PHARMACEUTICALS CORPORATION · Department of the Army | $3.2M | 2026-09-30 |